Publication
Decompressive Surgery in Cerebral Venous Sinus Thrombosis Due to Vaccine‐Induced Immune Thrombotic Thrombocytopenia
dc.contributor.author | Krzywicka, K | |
dc.contributor.author | Aguiar de Sousa, D | |
dc.contributor.author | Cordonnier, C | |
dc.contributor.author | Bode, F | |
dc.contributor.author | Field, T | |
dc.contributor.author | Michalski, D | |
dc.contributor.author | Pelz, J | |
dc.contributor.author | Skjelland, M | |
dc.contributor.author | Wiedmann, M | |
dc.contributor.author | Zimmermann, J | |
dc.contributor.author | Wittstock, M | |
dc.contributor.author | Zanotti, B | |
dc.contributor.author | Ciccone, A | |
dc.contributor.author | Bandettini di Poggio, M | |
dc.contributor.author | Borhani‐Haghighi, A | |
dc.contributor.author | Chatterton, S | |
dc.contributor.author | Aujayeb, A | |
dc.contributor.author | Devroye, A | |
dc.contributor.author | Dizonno, V | |
dc.contributor.author | Geeraerts, T | |
dc.contributor.author | Giammello, F | |
dc.contributor.author | Günther, A | |
dc.contributor.author | Ichaporia, N | |
dc.contributor.author | Kleinig, T | |
dc.contributor.author | Kristoffersen, E | |
dc.contributor.author | Lemmens, R | |
dc.contributor.author | De Maistre, E | |
dc.contributor.author | Mirzaasgari, Z | |
dc.contributor.author | Payen, JF | |
dc.contributor.author | Putaala, J | |
dc.contributor.author | Petruzzellis, M | |
dc.contributor.author | Raposo, N | |
dc.contributor.author | Sadeghi‐Hokmabadi, E | |
dc.contributor.author | Schoenenberger, S | |
dc.contributor.author | Umaiorubahan, M | |
dc.contributor.author | Sylaja, P | |
dc.contributor.author | van de Munckhof, A | |
dc.contributor.author | Sánchez van Kammen, M | |
dc.contributor.author | Lindgren, E | |
dc.contributor.author | Jood, K | |
dc.contributor.author | Scutelnic, A | |
dc.contributor.author | Heldner, M | |
dc.contributor.author | Poli, S | |
dc.contributor.author | Kruip, M | |
dc.contributor.author | Arauz, A | |
dc.contributor.author | Conforto, A | |
dc.contributor.author | Aaron, S | |
dc.contributor.author | Middeldorp, S | |
dc.contributor.author | Tatlisumak, T | |
dc.contributor.author | Arnold, M | |
dc.contributor.author | Coutinho, J | |
dc.contributor.author | Ferro, J | |
dc.date.accessioned | 2024-05-09T15:42:24Z | |
dc.date.available | 2024-05-09T15:42:24Z | |
dc.date.issued | 2023-05 | |
dc.description.abstract | Background and purpose: Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia (CVST-VITT) is an adverse drug reaction occurring after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. CVST-VITT patients often present with large intracerebral haemorrhages and a high proportion undergoes decompressive surgery. Clinical characteristics, therapeutic management and outcomes of CVST-VITT patients who underwent decompressive surgery are described and predictors of in-hospital mortality in these patients are explored. Methods: Data from an ongoing international registry of patients who developed CVST within 28 days of SARS-CoV-2 vaccination, reported between 29 March 2021 and 10 May 2022, were used. Definite, probable and possible VITT cases, as defined by Pavord et al. (N Engl J Med 2021; 385: 1680-1689), were included. Results: Decompressive surgery was performed in 34/128 (27%) patients with CVST-VITT. In-hospital mortality was 22/34 (65%) in the surgical and 27/94 (29%) in the non-surgical group (p < 0.001). In all surgical cases, the cause of death was brain herniation. The highest mortality rates were found amongst patients with preoperative coma (17/18, 94% vs. 4/14, 29% in the non-comatose; p < 0.001) and bilaterally absent pupillary reflexes (7/7, 100% vs. 6/9, 67% with unilaterally reactive pupil, and 4/11, 36% with bilaterally reactive pupils; p = 0.023). Postoperative imaging revealed worsening of index haemorrhagic lesion in 19 (70%) patients and new haemorrhagic lesions in 16 (59%) patients. At a median follow-up of 6 months, 8/10 of surgical CVST-VITT who survived admission were functionally independent. Conclusions: Almost two-thirds of surgical CVST-VITT patients died during hospital admission. Preoperative coma and bilateral absence of pupillary responses were associated with higher mortality rates. Survivors often achieved functional independence. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Eur J Neurol . 2023 May;30(5):1335-1345. | pt_PT |
dc.identifier.doi | 10.1111/ene.15735 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.17/4896 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Wiley | pt_PT |
dc.subject | HSJ NEU | pt_PT |
dc.subject | COVID-19 Vaccines* / adverse effects | pt_PT |
dc.subject | COVID-19* / prevention & control | pt_PT |
dc.subject | Coma | pt_PT |
dc.subject | Purpura, Thrombocytopenic, Idiopathic* / chemically induced | pt_PT |
dc.subject | Humans | pt_PT |
dc.subject | Purpura, Thrombocytopenic, Idiopathic* / surgery | pt_PT |
dc.subject | Sinus Thrombosis, Intracranial* / chemically induced | pt_PT |
dc.subject | Sinus Thrombosis, Intracranial* / surgery | pt_PT |
dc.subject | Thrombocytopenia* / chemically induced | pt_PT |
dc.subject | Thrombocytopenia* / surgery | pt_PT |
dc.title | Decompressive Surgery in Cerebral Venous Sinus Thrombosis Due to Vaccine‐Induced Immune Thrombotic Thrombocytopenia | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 1345 | pt_PT |
oaire.citation.issue | 5 | pt_PT |
oaire.citation.startPage | 1335 | pt_PT |
oaire.citation.title | European Journal of Neurology | pt_PT |
oaire.citation.volume | 30 | pt_PT |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |